Patents by Inventor Andreas Rytz

Andreas Rytz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nutritional composition comprising 2?-Fucosyllactose (2? FL) to improve the gastrointestinal barrier
    Patent number: 12257259
    Abstract: The present invention relates to nutritional compositions comprising 2?-Fucosyllactose (2?FL) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: March 25, 2025
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Clara Lucia Garcia-Rodenas, Jane Mea M Natividad, Andreas Rytz, Sami Damak, Norbert Sprenger, Francis Foata, Florence Rochat, Claire Laurence Lucie Marie Boulange
  • Compositions and methods for providing health benefits in an animal
    Patent number: 11896581
    Abstract: The present disclosure provides compositions and methods for providing a health benefit to an animal utilizing ferulic acid and histidine. For example, a composition can contain ferulic acid and histidine in therapeutically effective amounts for providing the health benefit to the animal.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: February 13, 2024
    Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
    Inventors: Francois-Pierre Martin, Christian Darimont-Nicolau, Andreas Rytz
  • A NUTRITIONAL COMPOSITION COMPRISING METABOLITES OF HMOS TO IMPROVE THE GASTROINTESTINAL BARRIER
    Publication number: 20220079988
    Abstract: The present invention relates to nutritional compositions comprising metabolites of HMOs to improve the gastrointestinal barrier. In particular, the invention relates to nutritional compositions comprising metabolites of HMOs for infants with impaired microbiota since their microbiota may not be able to metabolize HMOs.
    Type: Application
    Filed: December 9, 2019
    Publication date: March 17, 2022
    Inventors: Clara Lucia Garcia-Rodenas, Jane Mea M Natividad, Andreas Rytz
  • A NUTRITIONAL COMPOSITION COMPRISING 2'-FUCOSYLLACTOSE (2' FL) TO IMPROVE THE GASTROINTESTINAL BARRIER
    Publication number: 20220079963
    Abstract: The present invention relates to nutritional compositions comprising 2?-Fucosyllactose (2?FL) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.
    Type: Application
    Filed: December 11, 2019
    Publication date: March 17, 2022
    Inventors: Clara Lucia Garcia-Rodenas, Jane Mea M Natividad, Andreas Rytz, Sami Damak, Norbert Sprenger, Francis Foata, Florence Rochat, Claire Laurence Lucie Mari Boulange
  • COMPOSITIONS AND METHODS FOR PROVIDING HEALTH BENEFITS IN AN ANIMAL
    Publication number: 20220071962
    Abstract: The present disclosure provides compositions and methods for providing a health benefit to an animal utilizing ferulic acid and histidine. For example, a composition can contain ferulic acid and histidine in therapeutically effective amounts for providing the health benefit to the animal.
    Type: Application
    Filed: August 10, 2021
    Publication date: March 10, 2022
    Inventors: Francois-Pierre Martin, Christian DARIMONT-NICOLAU, Andreas RYTZ
  • A NUTRITIONAL COMPOSITION COMPRISING A COMBINATION OF HUMAN MILK OLIGOSACCHARIDES TO IMPROVE THE GASTROINTESTINAL BARRIER
    Publication number: 20220062311
    Abstract: The present invention relates to nutritional compositions comprising 2?-Fucosyllactose (2?FL), Di-fucosyllactose (Di-FL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3?-Sialyllactose (3?SL) and 6?-Sialyllactose (6?SL) for use in improving gastrointestinal barrier. In particular, the present invention relates to improving the gastrointestinal barrier in an infant, a young child or children aged above 3 years to 8 years.
    Type: Application
    Filed: December 11, 2019
    Publication date: March 3, 2022
    Inventors: Clara Lucia Garcia-Rodenas, Jane Mea M Natividad, Andreas Rytz